Pfizer Pushes 2nd Circ. To Ditch Patients' Lipitor Claims
Pfizer Inc. is asking the Second Circuit not to revive claims by a group of patients alleging its cholesterol drug Lipitor gave them Type 2 diabetes, saying federal preemption and the...To view the full article, register now.
Already a subscriber? Click here to view full article